ClinicalTrials.Veeva

Menu
N

Narodowy Instytut Onkologii im. Marii Sklodowskiej-Curie | Panstwowy Instytut Badawczy, Oddzial w Krakowie

Research site
(Unclaimed)

Site insights

Top conditions

Top treatments

Radium-223 Dichloride
Xofigo

Curious how this site stacks up to its peers?

Data sourced from clinicaltrials.gov

Work at this site?

CTV for research professionals allows users to enhance their site’s profile, add contact information, and more.

Learn more and claim site

Active trials

1 of 1 total trial

Investigation of Radium-223 Dichloride (Xofigo), a Treatment That Gives Off Radiation That Helps Kill Cancer Cells, Compared to a Treatment That Inactivates Hormones (New Antihormonal Therapy, NAH) in Patients With Prostate Cancer That Has Spread to the Bone Getting Worse on or After Earlier NAH

Researchers in this study want to compare how well drug radium-223 dichloride (Xofigo) and new (novel) anti-hormonal (NAH) therapy work in participan...

Active, not recruiting
Metastatic Castrate Resistant Prostate Cancer (mCRPC)
Drug: NAH therapy
Drug: Radium-223 dichloride (Xofigo, BAY88-8223)

Trial sponsors

Bayer logo

Clinical trials

Find clinical trialsTrials by location
© Copyright 2024 Veeva Systems